| | More

November 16, 2011

IN THIS ISSUE...

URGENT MESSAGE FROM THE ATS FOUNDATION

Between now and December 31, 2011, the Foundation must raise $225,000 to reach its annual goal of $500,000 for the ATS Foundation Research Program.Won't you please consider making a generous gift to help ensure the success of our campaign?

As leaders in the field, you know how important opportunities like the ATS Foundation Research Program are in advancing the careers of junior investigators in pulmonary, critical care and sleep medicine. By supporting the Foundation, you will help create a stronger pipeline of early-career scientists, essential to ensuring the progress of promising treatments for the one out of ten Americans burdened by the diseases you treat.

In addition to making your own personal gift to the Foundation's Funds for the Future annual campaign, we hope you will also encourage your colleagues to do the same.

To make a secure donation online, please visit: http://foundation.thoracic.org. Checks payable to the ATS Foundation may be sent to 25 Broadway, 18th Floor, New York, NY 10004.

Back to Top

VIEW HIGHLIGHTS FOR CLINICIANS WEBCASTS FOR A DISCOUNTED PRICE

If you were unable to attend ATS 2011, you can still benefit from the high-quality symposia and other sessions presented there. The ATS invites all pulmonary, critical care and sleep clinicians to access the Highlights for Clinicians Webcasts for a special discounted price of $275.

This package includes over 60 Webcast sessions from the ATS 2011 International Conference in Denver, Colorado. To take advantage of this special offer, we encourage you to:

Reminder: ATS members who attended ATS 2011 as full conference registrants can access this and other ATS 2011 Webcast series for free.

Back to Top

WEBINAR ON COPD FOR PATIENTS

This week is COPD Week at the ATS, and the highlight will be a Webinar today, Wednesday, November 16, at noon ET. The Webinar will be hosted by Byron Thomashow, MD, chair of the COPD Foundation; John Walsh, president of the COPD Foundation and Bill Clark, director of the foundation’s outreach programs. Learn more and register for the Webinar by clicking here.

Back to Top

LATEST BLUE JOURNAL INCUDES GUIDELINE ON PE IN PREGNANCY

The November 15 American Journal of Respiratory and Critical Care medicine includes an official ATS/Society of Thoracic Radiology clinical practice guideline on the evaluation of suspected pulmonary embolism in pregnancy It also includes a pulmonary perspective on TB drug development. To read the guideline, go to http://ajrccm.atsjournals.org.

Back to Top

BLUE JOURNAL PODCASTS ON VAP and NOBEL PRIZE WINNERS

The November 15 ARJCCM also includes a podcast interview with Dr. Jean Francois Timsit, professor of medicine and head of MICU at University of Grenoble (France) and Dr. Damon Scales, assistant professor of Medicine at University of Toronto.

Conducted by editorial board member Nitin Seam, the podcast is entitled “A re-appraisal of ventilator-associated pneumonia attributable mortality."

Dr. Timsit is a co-author of the original article “Attributable Mortality of Ventilator Associated Pneumonia: A Reappraisal Using Causal Analysis” and Dr. Scales wrote the accompanying editorial “Pneumonia in the ICU—A Lethal or VAPid Complication?”

The length of the podcast is approximately 24 minutes.

The December 1 AJRCCM will feature an editorial entitled “Innate and adaptive immunity: The 2011 Nobel Prize in Physiology or Medicine.”

The authors of the editorial, Aaron J. Ciechanover, of the Center for Cancer and Vascular Biology, at the Technion-Israel Institute of Technology in Haifa and AJRCCM editor Jacob I. Sznajder of Northwestern University, discuss how this year’s winners, Drs. Jules A. Hoffman, Bruce A. Beutler and the late Ralph M. Steinman, contributed to the field of innate and adaptive immunity.

Already posted to the journal’s Web site, the podcast is approximately 17 minutes long.

Both podcasts can be accessed by clicking here.

Back to Top

STRATTERA DRUG ALERT

An important FDA-approved drug alert for Strattera was delivered electronically to all ATS members who are registered with PDR® Network. If you have already registered to receive these alerts, please check your email for information regarding the alert.

If you have not yet registered to receive electronic PDR® Drug Alerts (HCNN), please do so athttp://www.ats.pdr.net. Your email or fax number will only be used to send and administer drug and device Alert services, FDA-approved drug labeling information and other clinically relevant PDR services/information.

Please take a moment to sign up for this free service designed to improve patient safety.

Back to Top

ABOUT ATS STAT

ATS Stat combines most of the e-mail messages you’d normally receive during the week from the ATS and puts them into a single message that arrives on Wednesdays. Questions or comments? Send them to Jennifer Ian, MBA, director of member services and chapter relations, at jian@thoracic.org.

Back to Top